International Consortium on the Genetics of Heroin Dependence

Request Access

Demographics (2)

age - Age (phv00171239.v1.p1)
sex - Gender (phv00171329.v1.p1)

Mental Health (89)

actalcohol - DSM-IV AD symptom - impt activities dropped (phv00171315.v1.p1)
actcannabis - DSM-IV MD symptom - impt activities dropped (phv00171271.v1.p1)
actcocaine - DSM-IV CD symptom - impt activities dropped (phv00171260.v1.p1)
actnicotine - DSM-IV ND symptom - impt activities dropped (phv00171325.v1.p1)
actopioid - DSM-IV HD symptom - impt activities dropped (phv00171304.v1.p1)
actsedative - DSM-IV ZD symptom - impt activities dropped (phv00171293.v1.p1)
actstimulant - DSM-IV SD symptom - impt activities dropped (phv00171282.v1.p1)
AFFECTION_STATUS - Affection status - assumes population controls are unaffected (phv00171234.v2.p1)
alcabuse - DSM-IV alcohol abuse (phv00171318.v1.p1)
alcoholdep4 - DSM-IV alcohol dependence (AD) - clustering not required (phv00171319.v1.p1)
canabuse - DSM-IV cannabis abuse (phv00171274.v1.p1)
cannabisdep4 - DSM-IV cannabis dependence (MD) - clustering not required (phv00171276.v1.p1)
canuse - Any lifetime use - cannabis (phv00171275.v1.p1)
canuselong - Longest period use almost daily - cannabis (phv00171240.v1.p1)
casestatus - Case status (phv00171253.v1.p1)
childtraumfactor - Childhood trauma second order factor score (phv00171254.v1.p1)
clusteralcohol - DSM-IV AD - clustering 3+ symptoms in 1 year (phv00171317.v1.p1)
clustercannabis - DSM-IV MD - clustering 3+ symptoms in 1 year (phv00171273.v1.p1)
clustercocaine - DSM-IV CD - clustering 3+ symptoms in 1 year (phv00171262.v1.p1)
clusternicotine - DSM-IV ND - clustering 3+ symptoms in 1 year (phv00171327.v1.p1)
clusteropioid - DSM-IV HD - clustering 3+ symptoms in 1 year (phv00171306.v1.p1)
clustersedative - DSM-IV ZD - clustering 3+ symptoms in 1 year (phv00171295.v1.p1)
clusterstimulant - DSM-IV SD - clustering 3+ symptoms in 1 year (phv00171284.v1.p1)
cocabuse - DSM-IV cocaine abuse (phv00171263.v1.p1)
cocainedep4 - DSM-IV cocaine dependence (CD) - clustering not required (phv00171265.v1.p1)
cocuse - Any lifetime use - cocaine (phv00171264.v1.p1)
cocuselong - Longest period use almost daily - cocaine (phv00171244.v1.p1)
contalcohol - DSM-IV AD symptom - continued use despite consequences (phv00171316.v1.p1)
contcannabis - DSM-IV MD symptom -continued use despite consequences (phv00171272.v1.p1)
contcocaine - DSM-IV CD symptom -continued use despite consequences (phv00171261.v1.p1)
contnicotine - DSM-IV ND symptom -continued use despite consequences (phv00171326.v1.p1)
contopioid - DSM-IV HD symptom -continued use despite consequences (phv00171305.v1.p1)
contsedative - DSM-IV ZD symptom -continued use despite consequences (phv00171294.v1.p1)
contstimulant - DSM-IV SD symptom -continued use despite consequences (phv00171283.v1.p1)
ftnd1 - Fagerstrom item 1 (phv00171247.v1.p1)
ftnd2 - Fagerstrom item 2 (phv00171248.v1.p1)
ftnd3 - Fagerstrom item 3 (phv00171249.v1.p1)
ftnd4 - Fagerstrom item 4 (phv00171246.v1.p1)
ftnd5 - Fagerstrom item 5 (phv00171250.v1.p1)
ftnd6 - Fagerstrom item 6 (phv00171251.v1.p1)
ftndtotal - Fagerstrom total score (phv00171252.v1.p1)
heroindep4 - DSM-IV heroin dependence (HD) - clustering not required (phv00171309.v1.p1)
intenalcohol - DSM-IV AD symptom - used more/longer than intended (phv00171312.v1.p1)
intencannabis - DSM-IV MD symptom - used more/longer than intended (phv00171268.v1.p1)
intencocaine - DSM-IV CD symptom - used more/longer than intended (phv00171257.v1.p1)
intennicotine - DSM-IV ND symptom - used more/longer than intended (phv00171322.v1.p1)
intenopioid - DSM-IV HD symptom - used more/longer than intended (phv00171301.v1.p1)
intensedative - DSM-IV ZD symptom - used more/longer than intended (phv00171290.v1.p1)
intenstimulant - DSM-IV SD symptom - used more/longer than intended (phv00171279.v1.p1)
nicotinedep4 - DSM-IV nicotine dependence (ND) - clustering not required (phv00171328.v1.p1)
opabuse - DSM-IV opioid abuse (phv00171307.v1.p1)
opuse - Any lifetime use - opioids (phv00171308.v1.p1)
opuselong - Longest period use almost daily - opioids (phv00171243.v1.p1)
quitalcohol - DSM-IV AD symptom - persistent desire quit (phv00171313.v1.p1)
quitcannabis - DSM-IV MD symptom - persistent desire quit (phv00171269.v1.p1)
quitcocaine - DSM-IV CD symptom - persistent desire quit (phv00171258.v1.p1)
quitnicotine - DSM-IV ND symptom - persistent desire quit (phv00171323.v1.p1)
quitopioid - DSM-IV HD symptom - persistent desire quit (phv00171302.v1.p1)
quitsedative - DSM-IV ZD symptom - persistent desire quit (phv00171291.v1.p1)
quitstimulant - DSM-IV SD symptom - persistent desire quit (phv00171280.v1.p1)
sedabuse - DSM-IV sedative abuse (phv00171296.v1.p1)
sedatdep4 - DSM-IV sedative dependence (ZD) - clustering not required (phv00171298.v1.p1)
seduse - Any lifetime use - sedatives (phv00171297.v1.p1)
seduselong - Longest period use almost daily - sedatives (phv00171242.v1.p1)
stimabuse - DSM-IV stimulant abuse (phv00171285.v1.p1)
stimdep4 - DSM-IV stimulant dependence (SD) - clustering not required (phv00171287.v1.p1)
stimuse - Any lifetime use - stimulants (phv00171286.v1.p1)
stimuselong - Longest period use almost daily - stimulants (phv00171241.v1.p1)
timealcohol - DSM-IV AD symptom - great deal time spent (phv00171314.v1.p1)
timecannabis - DSM-IV MD symptom - great deal time spent (phv00171270.v1.p1)
timecocaine - DSM-IV CD symptom - great deal time spent (phv00171259.v1.p1)
timenicotine - DSM-IV ND symptom - great deal time spent (phv00171324.v1.p1)
timeopioid - DSM-IV HD symptom - great deal time spent (phv00171303.v1.p1)
timesedative - DSM-IV ZD symptom - great deal time spent (phv00171292.v1.p1)
timestimulant - DSM-IV SD symptom - great deal time spent (phv00171281.v1.p1)
tolalcohol - DSM-IV AD symptom - tolerance (phv00171310.v1.p1)
tolcannabis - DSM-IV MD symptom - tolerance (phv00171266.v1.p1)
tolcocaine - DSM-IV CD symptom - tolerance (phv00171255.v1.p1)
tolnicotine - DSM-IV ND symptom - tolerance (phv00171320.v1.p1)
tolopioid - DSM-IV HD symptom - tolerance (phv00171299.v1.p1)
tolsedative - DSM-IV ZD symptom - tolerance (phv00171288.v1.p1)
tolstimulant - DSM-IV SD symptom - tolerance (phv00171277.v1.p1)
wdalcohol - DSM-IV AD symptom - withdrawal (phv00171311.v1.p1)
wdcannabis - DSM-IV MD symptom - withdrawal (phv00171267.v1.p1)
wdcocaine - DSM-IV CD symptom - withdrawal (phv00171256.v1.p1)
wdnicotine - DSM-IV ND symptom - withdrawal (phv00171321.v1.p1)
wdopioid - DSM-IV HD symptom - withdrawal (phv00171300.v1.p1)
wdsedative - DSM-IV ZD symptom - withdrawal (phv00171289.v1.p1)
wdstimulant - DSM-IV SD symptom - withdrawal (phv00171278.v1.p1)

Other (17)

ANALYTE_TYPE - Analyte Type (phv00192266.v2.p1)
BODY_SITE - Body site where sample was collected (phv00420521.v1.p1)
CONSENT - Consent group as determined by DAC (phv00171231.v2.p1)
control_groups - Control group identifier (phv00171330.v1.p1)
GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00420523.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00420522.v1.p1)
POOLED_SUBJECT_ID - Pooled subject ID (phv00430121.v1.p1)
SAMPLE_ID - Sample ID (phv00192265.v2.p1)
SAMPLE_ID - Sample identification number (phv00171236.v2.p1)
SAMPLE_USE - Sample Use (phv00171237.v2.p1)
SOURCE_SUBJECT_ID - Subject id within source (phv00171233.v2.p1)
STIMULATION - Treatment type applied (phv00420524.v1.p1)
study - Study of origin (phv00171245.v1.p1)
SUBJECT_ID - Sample identification number (phv00171238.v2.p1)
SUBJECT_ID - Subject identification number; subject ID "1" combines subject IDs 289101, 264401, 354701, 353601, 296001, 312501 (phv00171230.v2.p1)
SUBJECT_ID - Subject identification number (phv00171235.v2.p1)
SUBJECT_SOURCE - Source of subject with study name (phv00171232.v2.p1)